Patent ID: 11969410
Assignee: SOMERSET THERAPEUTICS, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. An ophthalmologically acceptable pharmaceutical composition for treating an ocular condition via administration to a mammalian eye (1) comprising between 1.15% and about 3% w/v of a pilocarpine compound, (2) comprising between about 0.05% and 0.18% w/v of a brimonidine compound, (3) (i) comprising a quaternary ammonium salt in an amount of about 0.003%-about 0.02% w/v and (ii) comprising a tonicity agent in an amount between about 0.005%-0.2% w/v, (4) the composition having a pH of between about 3-about 5.5, and (5) the ratio of the brimonidine compound to the tonicity agent being at least 1:1 and the ratio of the brimonidine compound to the quaternary ammonium salt being at least about 2.5:1.